Skip to main content
. 2014 Feb 13;7(4):1118–1122. doi: 10.3892/ol.2014.1881

Figure 1.

Figure 1

Representative immunohistochemical EGFR staining of a biopsy specimen prior to concurrent chemoradiotherapy. EGFR-positive; the percentage of immunoreactive tumor cells with staining grades of three or four are:50–74% and 75–100%, respectively. Magnification, ×100. EGFR, epidermal growth factor receptor.